These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 10404330

  • 1. A comparative study of the in-vitro activity of levofloxacin against Streptococcus pneumoniae.
    Reinert RR, Lütticken R, Lemperle M, Bryskier A.
    J Antimicrob Chemother; 1999 Jun; 43 Suppl C():5-8. PubMed ID: 10404330
    [Abstract] [Full Text] [Related]

  • 2. In-vitro activity of levofloxacin against Streptococcus pneumoniae with various levels of penicillin resistance.
    Thomson KS, Chartrand SA, Sanders CC, Block SL.
    J Antimicrob Chemother; 1999 Jun; 43 Suppl C():15-9. PubMed ID: 10404332
    [Abstract] [Full Text] [Related]

  • 3. In-vitro bacteriostatic activity of levofloxacin and three other fluoroquinolones against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
    Frémaux A, Sissia G, Geslin P.
    J Antimicrob Chemother; 1999 Jun; 43 Suppl C():9-14. PubMed ID: 10404331
    [Abstract] [Full Text] [Related]

  • 4. The susceptibility of Streptococcus pneumoniae to levofloxacin and other antibiotics.
    Keller N, Smollen G, Davidson Y, Barzilai A, Keren G, Rubinstein E.
    J Antimicrob Chemother; 1999 Jun; 43 Suppl C():1-3. PubMed ID: 10404329
    [Abstract] [Full Text] [Related]

  • 5. Moxifloxacin: a comparison with other antimicrobial agents of in-vitro activity against Streptococcus pneumoniae.
    Reinert RR, Schlaeger JJ, Lütticken R.
    J Antimicrob Chemother; 1998 Dec; 42(6):803-6. PubMed ID: 10052905
    [Abstract] [Full Text] [Related]

  • 6. Comparative in-vitro activity of levofloxacin against isolates of bacteria from adult patients with community-acquired lower respiratory tract infections.
    Casellas JM, Gilardoni M, Tome G, Goldberg M, Ivanovic S, Orduna M, Dolmann A, Ascoli M, Ariza H, Montero JM.
    J Antimicrob Chemother; 1999 Jun; 43 Suppl C():37-42. PubMed ID: 10404336
    [Abstract] [Full Text] [Related]

  • 7. Anti-pneumococcal activity of gatifloxacin compared with other quinolone and non-quinolone agents.
    Hoellman DB, Lin G, Jacobs MR, Appelbaum PC.
    J Antimicrob Chemother; 1999 May; 43(5):645-9. PubMed ID: 10382885
    [Abstract] [Full Text] [Related]

  • 8. In vitro susceptibilities of 176 clinical isolates of Streptococcus pneumoniae to 11 beta-lactams, erythromycin, and tetracycline.
    Vanhoof R, Carpentier M, Glupczynski Y, Gordts B, Magerman K, Nyssen HJ, Simon A, Surmont I, Van de Vyvere M, Van Landuyt H, Van Nimmen L, Van Noyen R.
    Acta Clin Belg; 1996 May; 51(6):377-85. PubMed ID: 8997755
    [Abstract] [Full Text] [Related]

  • 9. Comparative in vitro activity of levofloxacin, ofloxacin, and ciprofloxacin against ocular streptococcal isolates.
    Miller D, Alfonso EC.
    Cornea; 2004 Apr; 23(3):289-93. PubMed ID: 15084863
    [Abstract] [Full Text] [Related]

  • 10. Comparative susceptibility to penicillin and quinolones of 1385 Streptococcus pneumoniae isolates. Austrian Bacterial Surveillance Network.
    Buxbaum A, Straschil U, Moser C, Graninger W, Georgopoulos A.
    J Antimicrob Chemother; 1999 May; 43 Suppl B():13-8. PubMed ID: 10382870
    [Abstract] [Full Text] [Related]

  • 11. In vitro activity of gemifloxacin against Streptococcus pneumoniae isolates in Germany.
    Lemmen S, Al-Lahham A, Lütticken R, Reinert RR.
    Chemotherapy; 2001 May; 47(2):104-9. PubMed ID: 11173811
    [Abstract] [Full Text] [Related]

  • 12. In vitro antimicrobial activity of levofloxacin against Streptococcus pneumoniae.
    Hu BS, Fung CP, Liu PY, Lau YJ, Shi ZY, Lin YH.
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 Oct; 60(4):191-4. PubMed ID: 9439047
    [Abstract] [Full Text] [Related]

  • 13. [In vitro activities of levofloxacin and other antibiotics against fresh clinical isolates].
    Matsuzaki K, Koyama H, Chiba A, Omika K, Harada S, Sato Y, Hasegawa M, Kobayashi I, Kaneko A, Sasaki J.
    Jpn J Antibiot; 1999 Sep; 52(9):571-84. PubMed ID: 10746192
    [Abstract] [Full Text] [Related]

  • 14. Activity of moxifloxacin and twelve other antimicrobial agents against 216 clinical isolates of Streptococcus pneumoniae.
    Esposito S, Noviello S, Ianniello F.
    Chemotherapy; 2001 Sep; 47(2):90-6. PubMed ID: 11173809
    [Abstract] [Full Text] [Related]

  • 15. In vitro susceptibility of Streptococcus pneumoniae strains to nine beta-lactam antibiotics and the killing kinetics of cephalosporins alone and in combination with vancomycin or gentamicin.
    Marton A, Major P.
    Microb Drug Resist; 1996 Sep; 2(3):361-9. PubMed ID: 9158796
    [Abstract] [Full Text] [Related]

  • 16. Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacin.
    Spangler SK, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 1992 Apr; 36(4):856-9. PubMed ID: 1323956
    [Abstract] [Full Text] [Related]

  • 17. Susceptibility of penicillin-sensitive and -resistant strains of Streptococcus pneumoniae to new antimicrobial agents, including daptomycin, teicoplanin, cefpodoxime and quinolones.
    Appelbaum PC, Spangler SK, Crotty E, Jacobs MR.
    J Antimicrob Chemother; 1989 Apr; 23(4):509-16. PubMed ID: 2545656
    [Abstract] [Full Text] [Related]

  • 18. Surveillance of antibiotic resistance in clinical isolates of Streptococcus pneumoniae collected in Belgium during winter 2000-2001.
    Vanhoof R, Carpentier M, Cartuyvels R, Damée S, Fagnart O, Garrino MG, Glupczynski Y, Gordts B, Govaerts D, Magerman K, Mans I, Surmont I, Van Bossuyt E, Van De Vyvere M, Van Landuyt H, Van Nimmen L, Van Noyen R.
    Acta Clin Belg; 2003 Apr; 58(2):111-9. PubMed ID: 12836494
    [Abstract] [Full Text] [Related]

  • 19. Pharmacodynamics of levofloxacin and ofloxacin against Streptococcus pneumoniae.
    Bauernfeind A.
    J Antimicrob Chemother; 1999 Jun; 43 Suppl C():77-82. PubMed ID: 10404343
    [Abstract] [Full Text] [Related]

  • 20. Comparative activity of the new fluoroquinolone Bay y3118 against 177 penicillin susceptible and resistant pneumococci.
    Spangler SK, Jacobs MR, Appelbaum PC.
    Eur J Clin Microbiol Infect Dis; 1993 Dec; 12(12):965-7. PubMed ID: 8187796
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.